INSUBCONTINENT EXCLUSIVE:
NEW DELHI: Most pharma stocks looked lacklustre in morning trade on Tuesday.
The Nifty Pharma index was trading 0.13 per cent down at 9,174
around 10:15 am.
Cadila Healthcare (down 3.22 per cent), Glenmark Pharmaceuticals (down 1.60 per cent), Aurobindo Pharma (down 0.77 per
cent) and Piramal Enterprises (down 0.50 per cent) were the losers in the Nifty Pharma index
Shares of Cadila plunged after it said it would be acquiring a 51 per cent stake in Windlas Healthcare
Shares of Sun Pharmaceutical Industries (up 0.03 per cent) and Lupin (up 0.01 per cent) were almost flat around that time
Meanwhile, Cipla (up 0.41 per cent), Divi's Laboratories (up 0.39 per cent), Biocon (up 0.34 per cent) and Dr
Reddy's Laboratories (up 0.21 per cent) were trading with small gains
Equity market was in the positive territory amid mixed Asian cues
Gains in sectors, led by financial, metal, auto and FMCG boosted benchmark indices
The NSE Nifty50 index was up 57 points at 11,413, while the BSE Sensex was up 187 points at 37,832
Among the 50 stocks in the Nifty index, 34 were trading in the green, while 16 were in the red
Ultratech Cement, Axis Bank, Tech Mahindra, Bajaj Finance and Tata Steel were among the top gainers, while UPL, Vedanta, Larsen Toubro,
HPCL and Indiabulls Housing Finance were among the top losers in the Nifty index.
